• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.04% Nasdaq Up 0.56%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    68.28 Up 1.02(1.52%) 10:37AM EST - Nasdaq Real Time Price
    Prev Close:67.26
    Open:68.00
    Bid:67.94 x 200
    Ask:68.02 x 200
    1y Target Est:132.72
    Beta:1.7992
    Next Earnings Date:25-Feb-16BMRN Earnings announcement
    Day's Range:67.07 - 69.34
    52wk Range:62.12 - 151.75
    Volume:236,399
    Avg Vol (3m):1,669,830
    Market Cap:11.01B
    P/E (ttm):N/A
    EPS (ttm):-1.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BMRNUp 1.52%11.01B
    FOLDDown 2.48%638.89M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.13
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.63
    Quarterly EPS Est (Dec-15) :0.67
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-4.11

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback